Because IL-6, which is known to activate STAT3 in CLL cells [15], upregulated miR-155 levels, and STAT3-siRNA downregulated the expression miR-155, we concluded that STAT3 activates miR-155. This evidence concerns the gene IL6 and B-cell chronic lymphocytic leukemia.